Many programs are available from federal and state governments, non-profits, manufacturers, and other organizations to help you get the drugs you need at a reduced cost. Eligibility is often based on income, insurance or Medicare status, and other factors. You’ll need to apply through each program, either online, over the phone, or with your doctor's help. The following program is offered by the manufacturer of this drug.
|Program Name:||Actavis U.S. Patient Assistance Program|
|How do I apply?||Ask your doctor to help you submit an application. You can find the form on the program website, or request one by calling 1-800-851-0758.|
|What are the benefits?||You can enroll for 12 months at a time, and your medication will be shipped to your doctor or pharmacy every 90 days at no charge if you are approved.|
|What are the restrictions?||You will need a valid prescription, proof of gross monthly househould income, and a copy of your LIS denial letter (Medicare Part D only). Please contact the program for more information about income eligibility requirements.|
|Keep in mind||N/A|
You may find that filling a 90-day supply will reduce your total cost for this prescription. As an added bonus, you'll make fewer trips to the pharmacy, saving you time and money.
If you have insurance or Medicare, you may find that you receive lower prices if you fill your prescriptions through your plan’s mail order pharmacy. Many insurance plans (and most Medicare plans) are now offering similar rates at a select group of “preferred” retail pharmacies. Some plans may require that you fill through a mail order pharmacy for fills of more than a 30-day supply.
To switch to 90-day fills, note that you'll need a new prescription from your doctor; a 30-day quantity prescription will not allow 90-day fills.
It is possible that Savella may become available as generic milnacipran after September 2029. Generics are typically much cheaper than the branded version of a drug.
This is the earliest possible generic release date based on patent expiration at this time. It is possible that milnacipran could become available sooner or later, depending on FDA approval, other patents, and whether any manufacturers decide to make a generic version of Savella.